Www.metcardio.org REFRACTORY ANGINA : Definition, epidemiology, and management Giuseppe Biondi-Zoccai Ospedale S. Giovanni Battista “Molinette” Università.

Slides:



Advertisements
Similar presentations
Ranexa™ for Chronic Angina An Unmet Need
Advertisements

Stenting Patients Needing Non-Cardiac Surgery
STENT THROMBOSIS: WHICH IMPACT IN REAL CLINICAL PRACTICE? Giuseppe Biondi Zoccai Divisione di Cardiologia, Università di Torino Ospedale S. Giovanni Battista.
Can we prevent stent restenosis after coronary stent implantation
Spinal Cord Stimulators in Neuropathic Pain. Introduction Chronic pain is very common Immense physical, psychological, societal impact Financial burden.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Consent for Research Study RESCUE: Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic Examinations ACRIN
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
The Integrated Croydon Cardiac Rehabilitation Team Nurses - Sarah Hicks, Mary Stanley, Angela White, Elisabeth Visagie and Carmel Messenger Physiotherapist.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Ischemic heart disease. Indications and methods of surgical treatment. Surgery department №2.
New ESC/EACTS guidelines on myocardial revascularisation Indications for coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention.
Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.
Myocardial Ischemia Redefined: Optimal Care in CAD.
New guidelines for CABG
Management of Stable Angina SIGN 96
AMP (Angina Management Programme)
Nurse Co-ordinated Rapid Access Chest Pain Clinic
BARI 2D Trial BARI 2D Trial Presented at the American Diabetes Association (ADA) Annual Scientific Sessions 2009 in New Orleans The Bypass Angioplasty.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Applications of bivalirudin in interventional cardiology
Mechanism and Management of Coronary Microvascular Angina Dingcheng Xiang, MD, Ph.D Cardiovascular Department Liuhuaqiao Hosptial Guangzhou, China 广州军区广州总医院心血管内科向定成.
Silent Ischemia STABLE CAD
PCI vs. CABG: Review of the evidence and suggestions Giuseppe Biondi Zoccai Division of Cardiology, University of Turin, Turin, Italy.
Clinical Management of Chronic Stable Angina. Anti-ischemic strategies in stable CAD Medical therapyPCICABG Initial therapy Recurrent ischemia TMREECPSCS.
Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.
Multivessel PCI on top of culprit lesion revascularization? No way!
COMPLETE REVASCULARIZATION IN ELDERLY - When it’s contraindicated
SCS and IDDS: Patient Selection
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008.
PRACTICAL RECOMMENDATIONS ON ANTI- THROMBOTIC TREATMENT IN PATIENTS TREATED WITH DRUG-ELUTING STENTS Giuseppe Biondi-Zoccai Ospedale S. Giovanni Battista.
Contemporary Management of Myocardial Ischemia
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy BMS & Sanofi Aventis Sponsored.
Can we improve the management of angina patients after percutaneous coronary intervention? Beneficial effects of adding trimetazidine MR therapy after.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Multivessel Coronary Artery Disease
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.
Patient Beliefs Regarding Benefits of Percutaneous Coronary Intervention in Chronic Stable Angina My Summer Research Project of 2014 Carla Lauture, of.
Samuel Thomas Rayburn, III MD Cardiovascular Surgeon Jack Stephens Heart Institute April 25, 2015.
Survival Benefits in Higher Risk Patients Coronary Revascularization has Revolutionized the Therapy of Ischemic Heart Disease Acute coronary syndromes.
Prognosis of Patients With LV Dysfunction and CAD
The long-term impact of psychotherapy in patients with refractory angina Patel PA2, Ali N1, Thapar S1, Sainsbury PA1 1Department of Cardiology, Bradford.
Complex Coronary intervention
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
COLLABORATIVE APPROACH: CHRONIC PAIN MANAGEMENT FOR COMPLEX PATIENTS
Catheter-Based Treatment of Coronary Artery Disease
Giuseppe Biondi Zoccai
Recurrent Angina: New Tools for an Old Problem
Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,
Giuseppe Biondi Zoccai University of Turin, Turin, Italy
European Heart Association Journal 2007 April
Section 5: Intervention and drug therapy
Section F: Clinical guidelines
Giuseppe Biondi Zoccai, MD
Clinical tips and pearls
AN INTERNATIONAL COLLABORATIVE META-ANALYSIS ON 1,274 PATIENTS UNDERGOING PERCUTANEOUS DRUG-ELUTING STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
SURGERY EARLY AFTER DES IMPLANTATION
Benefits of complete coronary revascularization – Counterpoint: what are you talking about? Giuseppe Biondi Zoccai, MD University of Modena and Reggio.
American College of Cardiology Presented by Dr. Michel R. Le May
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Single Versus Multiple Vessel Stenting In Patients With St-Elevation Myocardial Infarction: Results From A 30,886-Patient Meta-Analysis Giuseppe Biondi.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Is Prasugrel Superior To Ticagrelor For The Treatment Of Patients With Acute Coronary Syndromes? Evidence From A 32,893-Patient Adjusted Indirect Comparison.
Clinical case report platform
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

REFRACTORY ANGINA : Definition, epidemiology, and management Giuseppe Biondi-Zoccai Ospedale S. Giovanni Battista “Molinette” Università di Torino Congresso Nazionale della Società Italiana di Cardiologia – Roma, 17 Dicembre 2007 (h )

What is refractory angina? -> Definition Does refractory angina really exist? -> Epidemiology Can I do anything about it? -> Management Learning goals

What is refractory angina? -> Definition Learning goals

Mechanism of angina pectoris DeJongste et al, Heart 2004 AUTONOMIC NERVOUS SYSTEM LIMBIC SYSTEM MECHANICAL AND CHEMICUAL STIMULI ?

Refractory angina: scope of the problem Abbate et al, Eur Heart J 2007 MICROVASCULAR DYSFUNCTION REFRACTORY ANGINA INCOMPLETE REVASCULARIZATION RECURRENT ANGINA

Recurrent angina: a true challenge Abbate et al, Eur Heart J 2007

(In)complete revascularization

Microvascular dysfunction Lanza, Heart 2007

Refractory angina: definitions ACC/AHA 2002 Guidelines Occurrence of chest pain due to myocardial ischemia in a patient with severe coronary artery disease who cannot be managed adequately by lifestyle adjustment or medical therapy and who are not candidates for revascularization (interventional or surgical) DeJongste et al, Heart

Refractory angina: definitions A chronic (>3 months) condition characterized by the presence of angina caused by coronary insufficiency in the presence of CAD which cannot be controlled by a combination of medical therapy, PTCA and CABG. The presence of reversible myocardial ischemia should be clinically established to be the cause of the symptoms. 3 Mannheimer et al, Eur Heart J 2002

Does refractory angina really exist? -> Epidemiology Learning goals

US burden of refractory angina Yang et al, MCP 2004

US burden of refractory angina Yang et al, MCP 2004

EU burden of refractory angina

EU burden of refractory angina Lenzen et al, EJCN 2006; Mannheimer et al, Eur Heart J 2002 Approximately 7% of people between 45 and 74 years suffer from angina pectoris. At least 14% of those in whom coronary revascularization is indicated are ineligible for it. Of all those with angina, 5-10% will develop refractory angina. This amounts to 30-50,000 persons/year.

Angina despite optimal therapy Boden et al, NEJM 2007

Angina despite optimal therapy Boden et al, NEJM 2007 † p<0.05 at 1 and 3 years, but not at 5 years; ¶ P<0.001 favoring PCI at all time points

Reasons for not performing PTCA/CABG DeJongste et al, Heart 2004

Typical patient features DeJongste et al, Heart 2004

Can I do anything about it? -> Management Learning goals

I’ve got this great new operation- I think it’ll help you Why don’t we ask him what he wants? How about angiogenesis? Thanks Doc (?) The doctor-centered approach VS The patient-centered approach

The patient-centered approach I.Level 1 A.Tell patients about procedure related morbidity and mortality and proceed II.Level 2 A.Inform patients of risks and benefits in dialogue and help them come to a decision III.Level 3 A.Don’t take symptoms for granted. What really is the problem?

The approach to the patient with refractory angina I.Pain history; is the chest pain angina? II.Assess red flags (unstable angina, prognostically important disease) III.Optimise anti-anginal therapy IV.Assess and address angina beliefs and fears V.Assess expectations in dialogue

Maximize drug therapy

The NORTHERN Trial of VEGF in refractory angina Stewart et al, TCT 2007

Referral to an experienced interventionist

Referral to an experienced cardiac surgeon

Still a role for PTCA/CABG: the MASS II Trial Hueb et al, Circ 2007

Newer treatments for refractory angina

Management of refractory angina: the Greater Manchester Experience Paravertebral block One-hour new patient appointment covering medical history, examination, education & distribution of patient information sheets psychology Individual psychology covering relaxation techniques, and cardiac health anxieties. Usually 4 – 6 sessions TENS machine TENS machine training from specialist nurses Follow up pain medical appointment to assess outcome of the first 2 treatment modalities. Assessment for stellate ganglion blockade Stellate ganglion block Medical review Implantable therapies: Spinal cord stimulation Intrathecal delivery systems Full angina pain management programme Cardiology review to exclude new disease Medical review Opioid analgesics TENS=Transcutaneous Electrical Nerve Stimulator

Promising role of spinal cord stimulation

Promising role of spinal cord stimulation

Take home messages

We must be ready to look for and listen to patients with refractory angina

Don’t be shy and truly maximize medical therapy

A comprehensive and individualized approach is likely more successful

A comprehensive and individualized approach is likely more successful DeJongste et al, Heart 2004

For further slides on these topics please feel free to visit the metcardio.org website: